Baker Bros. Advisors LP Gossamer Bio, Inc. Transaction History
Baker Bros. Advisors LP
- $7.9 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding GOSS
# of Institutions
114Shares Held
190MCall Options Held
405KPut Options Held
490K-
Nea Management Company, LLC Timonium, MD15.8MShares$14.3 Million1.31% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$12 Million0.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.6 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA9.2MShares$8.28 Million0.31% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.27 Million1.7% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $84.6M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...